IP Library Granted Patent US 10,835,547
Granted Patent B2
US 10,835,547 · App. 16/234,059 · Granted Nov 17, 2020

Methods and materials for reducing the risk of infections

Inventors: John W. Sperling (Rochester, MN); Adam A. Sassoon (Orlando, FL)
Assignee: Mayo Foundation for Medical Education and Research
A61K31/7056A61B46/00A61B46/20A61B46/40A61K9/0014A61K31/7048A61L15/44A61L31/16A61B2017/00889A61L2300/404A61L2300/406
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 10,835,547
App. No.
16/234,059
Granted
Nov 17, 2020
Kind
B2
Abstract

This document relates to methods and materials for reducing the risk of infection after a shoulder surgery or medical procedure. For example, this document relates to methods and materials for using a topical composition containing clindamycin or erythromycin to reduce the risk of or to prevent infection associated with shoulder surgeries or medical procedures.

Claims (5)

1. A method for reducing risk of a Propionibacterium acnes infection in a patient following a medical procedure, wherein said method comprises, during said procedure, applying a surgical drape comprising a topical antibacterial composition to at least a portion of the site of said medical procedure, wherein said topical antibacterial composition comprises clindamycin, erythromycin, or a combination thereof, wherein said patient does not develop a Propionibacterium acnes infection from said medical procedure.

2. The method of claim 1 , wherein said medical procedure is a shoulder steroid injection, a shoulder anesthetic injection, or a shoulder visco-supplementation injection.

3. The method of claim 1 , wherein said topical antibacterial composition comprises clindamycin.

4. The method of claim 1 , wherein said topical antibacterial composition comprises erythromycin.

5. The method of claim 1 , wherein said topical antibacterial composition comprises clindamycin and erythromycin.

Assignments (1)
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Apr 21, 2020
From: SPERLING, JOHN W.; SASSOON, ADAM A.
To: MAYO FOUNDATION FOR MEDICAL EDUCATION AND RESEARCH
Reel/Frame 052457/0577 →
Continuity (5)
Continuation 15699365 · Sep 8, 2017
Continuation 14874595 · Oct 5, 2015
Division 13659607 · Oct 24, 2012
Provisional Application 61550765 · Oct 24, 2011
Related Publication 20190125777A1 · May 2, 2019